OBJECTIVE: Cardiac transplantation (OHT) using diabetic donors (DDs) is thought to adversely influence survival. We attempt to determine if adult OHT can be safely performed using selected DDs. METHODS: The United Network for Organ Sharing (UNOS) database was examined for adult OHT from 2000 to 2010. RESULTS: Of the 20,348 patients undergoing OHT, 496 (2.4%) were with DDs. DDs were older (39.6 vs 31.3 years; P < .001), more likely female (41.5% vs 28.3%; P < .001), and had a higher body mass index (BMI) (29.9 vs 26.4; P < .001). Recipients of DD hearts were older (53.4 vs 51.8; P = .004) and more likely to have diabetes (18.9% vs 14.9%; P = .024). The 2 groups were evenly matched with regard to recipient male gender (78.0% vs 76.1%; P = .312), ischemic time (3.3 vs 3.2 hours; P = .191), human leukocyte antigen mismatches (4.7 vs 4.6; P = .483), and requirement of extracorporeal membrane oxygenation (ECMO) as a bridge to transplant (0.8% vs 0.5%; P = .382). Median survival was similar (3799 vs 3798 days; P = .172). On multivariate analysis, DD was not associated with mortality (hazard ratio [HR], 1.155; 95% confidence interval [CI], 0.943-1.415; P = .164). As previously demonstrated, donor age, decreasing donor BMI, ischemic time, recipient creatinine, recipient black race, recipient diabetes, race mismatch, and mechanical ventilation or ECMO as a bridge to transplant were associated with mortality. On multivariate analysis of subgroups, neither insulin-dependent diabetes (1.173; 95% CI, 0.884-1.444; P = .268) nor duration of diabetes for more than 5 years (HR, 1.239; 95% CI, 0.914-1.016; P = .167) was associated with mortality. CONCLUSIONS: OHT can be safely performed using selected DDs. Consensus criteria for acceptable cardiac donors can likely be revised to include selected DDs.
OBJECTIVE: Cardiac transplantation (OHT) using diabetic donors (DDs) is thought to adversely influence survival. We attempt to determine if adult OHT can be safely performed using selected DDs. METHODS: The United Network for Organ Sharing (UNOS) database was examined for adult OHT from 2000 to 2010. RESULTS: Of the 20,348 patients undergoing OHT, 496 (2.4%) were with DDs. DDs were older (39.6 vs 31.3 years; P < .001), more likely female (41.5% vs 28.3%; P < .001), and had a higher body mass index (BMI) (29.9 vs 26.4; P < .001). Recipients of DD hearts were older (53.4 vs 51.8; P = .004) and more likely to have diabetes (18.9% vs 14.9%; P = .024). The 2 groups were evenly matched with regard to recipient male gender (78.0% vs 76.1%; P = .312), ischemic time (3.3 vs 3.2 hours; P = .191), human leukocyte antigen mismatches (4.7 vs 4.6; P = .483), and requirement of extracorporeal membrane oxygenation (ECMO) as a bridge to transplant (0.8% vs 0.5%; P = .382). Median survival was similar (3799 vs 3798 days; P = .172). On multivariate analysis, DD was not associated with mortality (hazard ratio [HR], 1.155; 95% confidence interval [CI], 0.943-1.415; P = .164). As previously demonstrated, donor age, decreasing donor BMI, ischemic time, recipient creatinine, recipient black race, recipient diabetes, race mismatch, and mechanical ventilation or ECMO as a bridge to transplant were associated with mortality. On multivariate analysis of subgroups, neither insulin-dependent diabetes (1.173; 95% CI, 0.884-1.444; P = .268) nor duration of diabetes for more than 5 years (HR, 1.239; 95% CI, 0.914-1.016; P = .167) was associated with mortality. CONCLUSIONS: OHT can be safely performed using selected DDs. Consensus criteria for acceptable cardiac donors can likely be revised to include selected DDs.
Keywords:
34; BMI; CI; ECMO; HR; UNOS; United Network for Organ Sharing; body mass index; confidence interval; extracorporeal membrane oxygenation; hazard ratio
Authors: Alfred A Bove; Abul Kashem; Robert C Cross; Joyce Wald; Satoshi Furukawa; Gail O Berman; James B McClurken; Howard J Eisen Journal: J Heart Lung Transplant Date: 2005-11-02 Impact factor: 10.247
Authors: David O Taylor; Leah B Edwards; Mark M Boucek; Elbert P Trulock; Paul Aurora; Jason Christie; Fabienne Dobbels; Axel O Rahmel; Berkeley M Keck; Marshall I Hertz Journal: J Heart Lung Transplant Date: 2007-08 Impact factor: 10.247
Authors: Brian Lima; Keshava Rajagopal; Rebecca P Petersen; Ashish S Shah; Beth Soule; G Michael Felker; Joseph G Rogers; Andrew J Lodge; Carmelo A Milano Journal: Circulation Date: 2006-07-04 Impact factor: 29.690
Authors: Nishant D Patel; Eric S Weiss; Lois U Nwakanma; Stuart D Russell; William A Baumgartner; Ashish S Shah; John V Conte Journal: Circulation Date: 2008-09-30 Impact factor: 29.690
Authors: Jeffrey A Morgan; Ranjit John; Alan D Weinberg; Aftab R Kherani; Nicholas J Colletti; Deon W Vigilance; Faisal H Cheema; Gianluigi Bisleri; Thomas Cosola; Donna M Mancini; Mehmet C Oz; Niloo M Edwards Journal: J Thorac Cardiovasc Surg Date: 2003-11 Impact factor: 5.209
Authors: C I Tsao; R J Chen; N K Chou; W J Ko; N H Chi; H Y Yu; Y S Chen; S C Chen; S S Wang Journal: Transplant Proc Date: 2008-10 Impact factor: 1.066
Authors: M T Izquierdo; L Almenar; L Martínez-Dolz; J Moro; J Agüero; I Sánchez-Lázaro; O Cano; V Ortiz; R Sánchez; A Salvador Journal: Transplant Proc Date: 2007-09 Impact factor: 1.066
Authors: Josef Stehlik; David S Feldman; Robert N Brown; Adrian B VanBakel; Stewart D Russel; Gregory A Ewald; Mary E Hagan; Jan Folsom; James K Kirklin Journal: J Heart Lung Transplant Date: 2009-10-04 Impact factor: 10.247
Authors: Vishnu Ambur; Sharven Taghavi; Senthil Jayarajan; John Gaughan; Yoshiya Toyoda; Elizabeth Dauer; Lars Ola Sjoholm; Abhijit Pathak; Thomas Santora; Amy J Goldberg Journal: Ann Med Surg (Lond) Date: 2016-03-19